Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125073364 | 12507336 | 4 | F | 20160805 | 20160629 | 20160817 | EXP | GB-MHRA-ADR 23517685 | GB-ACCORD-041811 | ACCORD | 63.00 | YR | M | Y | 0.00000 | 20160817 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125073364 | 12507336 | 1 | PS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 79068 | ||||||||||
| 125073364 | 12507336 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 0 | 345 | MG | |||||||||
| 125073364 | 12507336 | 3 | SS | XGEVA | DENOSUMAB | 1 | Subcutaneous | U | 0 | 120 | MG | SOLUTION FOR INJECTION | |||||||
| 125073364 | 12507336 | 4 | SS | NEULASTA | PEGFILGRASTIM | 1 | U | 0 | |||||||||||
| 125073364 | 12507336 | 5 | C | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | 0 | ||||||||||||
| 125073364 | 12507336 | 6 | C | CHLORPHENAMINE/CHLORPHENAMINE MALEATE/CHLORPHENAMINE RESINATE/CHLORPHENAMINE TANNATE | 2 | 0 | |||||||||||||
| 125073364 | 12507336 | 7 | C | FORCEVAL | FOLIC ACIDIRONMINERALSVITAMINS | 1 | 0 | ||||||||||||
| 125073364 | 12507336 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 125073364 | 12507336 | 9 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 125073364 | 12507336 | 10 | C | OXYCODONE/OXYCODONE HYDROCHLORIDE/OXYCODONE PECTINATE/OXYCODONE TEREPHTHALATE | 2 | 0 | |||||||||||||
| 125073364 | 12507336 | 11 | C | PREGABALIN. | PREGABALIN | 1 | 0 | ||||||||||||
| 125073364 | 12507336 | 12 | C | THIAMINE. | THIAMINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125073364 | 12507336 | 1 | Product used for unknown indication |
| 125073364 | 12507336 | 2 | Product used for unknown indication |
| 125073364 | 12507336 | 3 | Product used for unknown indication |
| 125073364 | 12507336 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125073364 | 12507336 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125073364 | 12507336 | Alopecia | |
| 125073364 | 12507336 | Arthralgia | |
| 125073364 | 12507336 | Chronic obstructive pulmonary disease | |
| 125073364 | 12507336 | Dyspnoea exertional | |
| 125073364 | 12507336 | Failure to anastomose | |
| 125073364 | 12507336 | Insomnia | |
| 125073364 | 12507336 | Neuropathy peripheral | |
| 125073364 | 12507336 | Skin ulcer | |
| 125073364 | 12507336 | Spinal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125073364 | 12507336 | 1 | 20160601 | 0 | ||
| 125073364 | 12507336 | 3 | 20160518 | 0 |